AVE
Avecho Biotechnology Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
5
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system Tocopherol Phosphate Mixture (TPM). The firm's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, Daptomycin, Propofol and Veterinary Applications. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Company’s Human Health segment covers delivery of pharmaceutical products through gels, injectables and patches. This segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. The firm is also developing TPM to enhance feed efficiency and health of livestock. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
📈 Performance
Price History
-97.07%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.01
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in AVE
5
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in AVE
585 days
AVE investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
17%
50k - 100k
50%
Less than 50k
33%
👶 Age of investors
18 - 25
26 - 34
60%
35 - 90
40%
🙋 Legal gender of investors
Female
60%
Male
40%
Pearlers who invest in AVE also invest in...
Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system Tocopherol Phosphate Mixture (TPM). The firm's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, Daptomycin, Propofol and Veterinary Applications. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Company’s Human Health segment covers delivery of pharmaceutical products through gels, injectables and patches. This segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. The firm is also developing TPM to enhance feed efficiency and health of livestock. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 2975.21m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
📊 Share price
$120.79 AUD
NULL AUSTRALIA
NULL BETA
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
📊 Share price
$29.97 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
FAIR.AX was created on 2017-11-27 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes Australian companies that have passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
📊 Share price
$18.55 AUD
NULL AUSTRALIA
NULL NEW ZEALAND
NULL ETHICAL
NULL THEMATIC
NULL SUSTAINABLE
Want more shares? Try these...
Auctus Investment Group Ltd. primary focus is to invest into companies and platforms operating in growth sectors. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-08-10. The firm is focused on opportunities across private equity, infrastructure and operating real-estate. The company invests in growth sectors with tailwinds and significant potential to scale. The firm provides access to these private market opportunities via investment funds to wholesale, family office, and institutional investors.
📊 Share price
$0.92 AUD
AVADA Group Ltd. engages in the provision of traffic management and ancillary service. The company is headquartered in Brisbane, Queensland. The company went IPO on 2021-12-17. The firm operates through three segments: Queensland Traffic Management, New South Wales Traffic Management, and Victoria Traffic Management. Queensland Traffic Management contains entities which operate in the Queensland geography. New South Wales Traffic Management contains entities which operate in the New South Wales geography. Victoria Traffic Management contains entities which operate in the Victorian geography. The firm provides services to government clients and major contractors in the civil infrastructure and maintenance sector. Its businesses include Verifact Traffic, A2O Traffic Solutions, D&D Traffic Management, Platinum Traffic Services, Traffic Marshal, Construct Traffic, TRAFFIC MANAGEMENT PEOPLE (TMP) and Linemark Traffic Control.
📊 Share price